# Cyteir Therapeutics, Inc. — Form D

Cyteir Therapeutics, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-15. $20.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-10-15
- Form: D
- Accession: 0001662244-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $20.2M
- Investors: 6
- Date of first sale: 2019-09-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-350987

## Issuer

- Name: Cyteir Therapeutics, Inc.
- CIK: 0001662244
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 128 SPRING STREET, LEXINGTON, MA, 02421
- Phone: 857-285-4140

## Officers, directors & promoters (23)

| Name | Role | Location |
| --- | --- | --- |
| TIMOTHY ROMBERGER | Director | LEXINGTON, MA |
| TIMOTHY ROMBERGER | Executive Officer | LEXINGTON, MA |
| Kevin Mills | Director | Fremont, CA |
| Kevin Mills | Executive Officer | Fremont, CA |
| Janwillem Naesens | Director | San Francisco, CA |
| Joseph S Zakrzewski | Director | Denver, CO |
| Karen Hong | Director | Princeton, NJ |
| TIMOTHY S ROMBERGER | Director | LEXINGTON, MA |
| PAUL S SECRIST | Executive Officer | LEXINGTON, MA |
| ANDREW S GENGOS | Executive Officer | LEXINGTON, MA |
| SUSAN S MOLINEAUX | Director | LEXINGTON, MA |
| JEAN GEORGE | Director | LEXINGTON, MA |
| RACQUEL BRACKEN | Director | LEXINGTON, MA |
| MARKUS RENSCHLER | Director | LEXINGTON, MA |
| MARKUS RENSCHLER | Executive Officer | LEXINGTON, MA |
| Bart Van Hooland | Director | Cambridge, MA |
| Ronald Goldstein | Executive Officer | Cambridge, MA |
| Barry Mills | Director | Cambridge, MA |
| Donald Corcoran | Director | Cambridge, MA |
| Donald Corcoran | Executive Officer | Cambridge, MA |
| William B Asher, Jr. | Executive Officer | Cambridge, MA |
| Timothy B Romberger | Director | Cambridge, MA |
| Barry B Mills | Director | Cambridge, MA |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-02-17](https://search.stillhousedata.com/formd/0001662244-21-000001) | D | — | $80.0M |
| [2018-05-16](https://search.stillhousedata.com/formd/0001662244-18-000002) | D/A | $35.0M | $5.8M |
| [2018-03-28](https://search.stillhousedata.com/formd/0001662244-18-000001) | D | $29.0M | $4.8M |
| [2016-11-16](https://search.stillhousedata.com/formd/0001662244-16-000003) | D/A | $5.8M | $5.8M |
| [2015-12-30](https://search.stillhousedata.com/formd/0001662244-15-000001) | D | $5.7M | $5.7M |

## More

- [CIK 1662244 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1662244&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001662244-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.